Nefazodone and REM sleep: How do antidepressant drugs decrease REM sleep?

Sleep

Volumn 21, Issue 1, 1998, Pages 70-77

  Vogel, Gerald ^a,b   Cohen, Jonathan ^a   Mullis, Deidre ^a   Kensler, Terry ^a   Kaplita, Stephen ^a  

^a Sleep Research Laboratory   (United States)

^b GMHI   (United States)

Author keywords

Antidepressant drugs; Nefazodone; REM sleep; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; NEFAZODONE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NIGHT SLEEP; NONREM SLEEP; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SEROTONINERGIC TRANSMISSION; STATISTICAL ANALYSIS;

EID: 0031885916     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/21.1.70     Document Type: Article

References (45)

1. Eison AS, Eison MS, Torrente JR, Wright BN, Yocca FD. Nefazodone: Preclinical pharmacology of a new antidepressant. Psychopharm Bull 1990; 26:311-5.
2. Ware JC, Rose FV, McBrayer RH. The acute effects of nefazodone, trazodone, and busiprone on sleep and sleep-related penile tumescence in normal subjects. Sleep 1994;17:544-50.
3. Feighner JP, Pambakian R, Fowler RC, Boyer WF, D'Amico MF. A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression. Psychopharmacol Bull 1989; 25:219-21.
4. Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. J Clin Psychiatry 1996; 57(suppl2):15-18.
5. Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G. A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry 1994;55:234-241
6. Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients. J Clin Psychiatry 1995;56(suppl 6):30-36.
7. Rickels K, Schweizer E, Clary C, et al. Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatry 1994;164:802-805.
8. Richelson E. Pharmacology of antidepressants - characteristics of the ideal drug. Mayo Clin Proc 1994;69:1069-1081.
9. Vogel GW, Buffenstein A, Minter K, Hennessey A. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 1990;14:49-63.
10. Nicholson AN, Pascoa PA. Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5HT uptake inhibitor. Neuropharmacol 1988;27:597-602.
11. Vasar V, Appelberg B, Rimon R, Selvaratum J. The effect of fluoxetine on sleep: a longitudinal double-blind polysomnographic study of healthy volunteers. Internat Clin Psychopharmacol 1994;9:203-6.
12. Hendrichse WA, Roffwarg HP, Grannemann BD, Orsulak PJ, Armitage R, Cain JW, Battaglia J, Bedus JR, Rush AJ. The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study. Neuropsychopharmacol 1994; 10:85-91.
13. Kupfer D. Interactions of EEG sleep, antidepressants and affective disease. J Clin Psychiatry 1982;2:8-13.
14. Shipley JE, Kupfer DJ, Dealy RS, Griffin SJ, Coble PA, McEachran AD, Grochocinski VJ. Differential effects of amitriptyline and of zimeldine on sleep electro-encephalograms of depressed patients. Clin Pharmacol Ther 1984;34:251-9.
15. Maudhuit C, Jolas T, Lainey E, Hamon M, Adrien J. Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat. Neuropharmacol 1994;33:1017-25.
16. van Bemmel AL, van dan Hoofdakker RH, Beersma DG, Bouhuys AL. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacol 1993;113:225-30.
17. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Wolf R. Sleep laboratory studies on the single-dose effect of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 1991;14:439-47.
18. Dilger MS, Goldberg R, DiPhillipo M, Fry JM. REM sleep suppression and paroxetine. Sleep Res 1995;24:42.
19. Staner L, Kerhofs J, Detroux D, Leyman S, Linkowski P, Mendlewicz J. Acute, subchronic, and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind, randomized trial in major depression. Sleep 1995;18:470-477.
20. Sewitch DE, Biniaur IV, Phillips JL, Winokur A. Sleep architecture and mood effects of sertraline in outpatients with major depression: a preliminary report. Sleep Res 1991;20:189.
21. Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg H. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacol 1994;10:123-7.
22. Sharpley AL, Walsh AES, Cowen PW. Nefazodone - a novel anti-depressant may increase REM sleep. Biol Psychiatry 1992;31:1070-3.
23. Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, Vogel G, Kaplita S, Fleming J, Montplaisir J, Erman MK, Albala BJ. Comparative effects of nefazodone and fluoxetine on sleep in subjects with major depressive disorders. Manuscription preparation.
24. Sharpley AL, Williamson DJ, Attenburrow MEJ, Pearson G, Sargent P, Cowen PJ. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacol 1996;126:50-54.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition - Revised. (DSM-III-R). American Psychiatric Association. Washington, D.C. 1987.
26. Rechtschaffen A, Kales A. A manual for standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service, 1968.
27. Vogel, GW, Thurmond A, Gibbons P, Sloan K, Boyd M, Walker M. REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry 1975;32:765-77.
28. Vogel, GW. Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Prog Neuropsycholpharmacol Biol Psychiatry 1983;7:343-349.
29. Taylor DP, Eison MS, Riblet LA, Temple DL JR, Yevich JP, Smith DW. Selective 5-HT2 receptor blockade: Pharmacologic studies of MJ13754, a nontricyclic antidepressant candidate. Soc Neurosci Abstr 1982;8:465.
30. Tortelle FC, Echevarria E, Pastel RH, Cox B, Blackburn TP. Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats. Brain Res 1989;485:294-300.
31. Dugovic C, Wanguier A, Leysen JE, Marrannes R, Janssen PAJ. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacol 1989;97:436-42.
32. Lawler, BA, Newhouse PA, Balkin TJ, Molchan SE, Mellow AM, Murphy DL, Sunderland T. A preliminary study of the effects of night-time administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers. Biol Psychiatry 1991;29:281-6.
33. Scherschlict R, Pole P, Schneeberger J, Steiner M, Haefely W. Selective suppression of rapid eye movement sleep (REMS) in cats by typical and atypical antidepressants. In: Costa E, Tacagni G, eds. Typical and atypical antidepressants: molecular mechanisms. New York: Raven Press, 1982:359-364.
34. Steininger TL, Rye DB, Wainer BH. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. J Comp Neurol 1992;321:515-43.
35. Steininger TL, Wainer BH. Anatomical connections of the serotonergic dorsal raphé nucleus with the cholinergic pedunculopontine and laterodorsal tegmental nuclei in rats. Sleep Res 1983;22:456.
36. Steriade M, McCarley RW. Brainstem Control of Wakefulness and Sleep. New York. Plenum Press, 1990.
37. McGinty DJ, Harper RM. Dorsal raphé neurons: Depression of firing during sleep in cats. Brain Res 1976;101:569-575.
38. Leonard CS, Llinas R. Serotonin (5-HT) inhibits mesopontine cholinergic neurons in vitro. Soc Neurosci Abstr 1990;16:1223.
39. Leubke JI, Green RW, Semba K, Kamordi A, McCarley RW, Reiner PB. Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro. Proc Natl Acad Sci USA 1992;89:743-7.
40. Sheard MH, Zolovick A, Aghajanian GK, Raphé neurons: effect of tricyclic antidepressant drugs. Brain Res 1972;43:690-4.
41. Scuvée-Moreau JJ, Dresse AE. Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphé neurons of the rat. Europ J Pharmacol 1979;57:219-25.
42. Quinaux N, Scuvée-Moreau J, Dresse J. Inhibition of in vitro and ex vivo uptake of noradrenaline and 5=hydroxytryptamine by five antidepressants: correlation with reduction of spontaneous firing rate of central monoaminergic neurons. Nawyn-Schmiedeberg's Arch Pharmacol 1982;319:66-70.
43. de Montigny C, Blier P. Electrophysiological aspects of serotonin neuropharmacology: implications for antidepressant treatments. In: Green AR. Neuropharmacology of Serotonin. Oxford University Press. Oxford 1985;181-95.
44. Aghajanian GK, Graham AW, Sheard MH. Serotonin containing neurons in brain: Depression of firing by monoamine oxidase inhibitors. Science 1970;169:1100-2.
45. Bramwell G. The effect of antidepressants on unit activity in the midbrain raphé of rats. Arch Intern Pharmacodyn 1974;211:24-33.